Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 5 Neoplasms 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Mucositis 2 Malnutrition 2 Lung Neoplasms 2 Diarrhea 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Radiation Injuries 1 Psychological Well-Being 1 Psoriasis Vulgaris 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Pelvic Inflammatory Disease 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Metformin 119 Clomiphene 39 Letrozole 31 Inositol 30 Folic Acid 16 Exercise 13 Chorionic Gonadotropin 13 drospirenone and ethinyl estradiol combination 11 Progesterone 11 Ethinyl Estradiol 11 Estradiol 10 Caloric Restriction 10 cetrorelix 9 Contraceptives, Oral 9 Triptorelin Pamoate 8 Spironolactone 8 Pioglitazone 8 Diet 8 Tablets 7 Menotropins 7 High-Intensity Interval Training 7 Acupuncture Therapy 7 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Gonadotropins 6 Exenatide 6 Cholecalciferol 6 follitropin alfa 5 drospirenone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04593459 2024-03-22

ProPCO-RCT

Medical University of Graz

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡